Aignostics
Pre-clinicalAignostics turns complex biomedical data into transformative insights for biopharma companies through development of AI-powered precision medicine for pathology throughout the drug development pipeline from target identification, to translational research, and trials & companion diagnostics.
Founded
2018
Focus
AI / Machine LearningOncologyDigital Health
About
Aignostics turns complex biomedical data into transformative insights for biopharma companies through development of AI-powered precision medicine for pathology throughout the drug development pipeline from target identification, to translational research, and trials & companion diagnostics.
Funding History
2Total raised: $13.5M
Series A$10MMIG CapitalMar 15, 2023
Seed$3.5MHigh-Tech GründerfondsJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationBerlin, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile